(NASDAQ:AVXL), NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced the appointment of Wolfgang […]

(NasdaqGM:VERA), BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (“Vera Therapeutics”), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced that the Company's management team will present at the 44th Annual J.P. Morgan Healthcare Conference, which is taking place in San

(NasdaqGM:PFSA), Dr. Theodosios Bisdas is a renowned vascular surgeon and Head of Clinic of Vascular Surgery at the Athens Medical Center BERKELEY, Calif, Jan. 08, 2026 (GLOBE NEWSWIRE) — Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of

(TSX-V:MD),(TSX-V:MD), MONTREAL, Jan. 08, 2026 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD), in partnership with Rio Tinto Exploration Canada Inc. (“RTEC“), is pleased to announce the results of the 2025 drilling campaign for lithium on the Galinee project. The Galinee project is located approximately 5 kilometres east of the Adina lithium deposit held

(TSX:GURU), MONTRÉAL, Jan. 08, 2026 (GLOBE NEWSWIRE) — GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company“), Canada's leading organic energy drink brand1, will report its financial results for the fourth quarter and fiscal year ended October 31, 2025 on Thursday, January 22, 2026, before markets open. Management will hold a conference call to

(NASDAQ:ZVRA), CELEBRATION, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) — Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced that members of Zevra's executive leadership team will present at the J.P. Morgan 44th Annual Healthcare Conference in San Francisco, CA on

(NYSE:ENOV), Dallas, TX, Jan. 08, 2026 (GLOBE NEWSWIRE) — Enovis(TM) Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors at the 44th Annual J.P. Morgan Healthcare Conference with a presentation scheduled for Monday, January 12th, 2026, at 4:30 p.m. PST (7:30 p.m. EST). A link

(NASDAQ:BENF), DALLAS, Jan. 08, 2026 (GLOBE NEWSWIRE) — Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced it has closed on the financing of an approximately $3 million primary capital commitment for Cork &

(NYSE:FCN), WASHINGTON, Jan. 08, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Joshua Baca as a Senior Managing Director. Mr. Baca, who is based in Washington, D.C., joins FTI Consulting's Strategic Communications segment with more than 20 years of experience at the intersection of government, business and reputation. In

(TSX:AGF-B),(TSX:AGF.B),(TSX:AGFB),(TSX:AMGR),(TSX:AGSL), TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) announced today the launch of ETF series units for AGF American Growth Fund and AGF Global Select Fund, providing investors with access to legacy funds with long-standing, proven track records in an ETF series. “This launch expands our ETF lineup and responds